In Illinois, LanzaTech NZ Inc. has successfully engineered specialized biocatalysts to directly produce ethylene from CO2 in a continuous process. This breakthrough in bacterium bio-engineering from LanzaTech represents a potential source of advancement towards the company’s mission of replacing fossil-based feedstocks used in the manufacture of everyday consumer goods with waste carbon. In addition to the potential broad reaching implications for global carbon reduction and sustainability, the development represents a significant opportunity for LanzaTech to further penetrate the global ethylene market, which is estimated at approximately $125 billion in 2022.
